<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119166">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01671670</url>
  </required_header>
  <id_info>
    <org_study_id>2012CB518501-3</org_study_id>
    <secondary_id>2012CB518501</secondary_id>
    <nct_id>NCT01671670</nct_id>
  </id_info>
  <brief_title>Acupuncture for Patients With Function Dyspepsia</brief_title>
  <official_title>Phase III Study of Acupuncture for Patients With Functional Dyspepsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hunan University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chengdu University of Traditional Chinese Medicine</source>
  <oversight_info>
    <authority>China: Ministry of Science and Technology</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Acupuncture is efficacious and safe for patients with functional dyspepsia

      Design:

        -  A single blind randomized controlled trial

        -  200 participants will be included

        -  Two arms: acupuncture and sham acupuncture group
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: to clarify the efficacy and safety of acupuncture for patients with functional
      dyspepsia Design: A single blind randomized controlled trial will be performed in Chengdu,
      Hunan and Chongqing province. Two hundred participants will be randomly assign to
      acupuncture and sham acupuncture group. Each participants will receive 20 sessions of
      acupuncture in 4 weeks, with a duration of 30 minutes in a session. The primary outcome is
      Patients' global assessments of efficacy in 16 weeks after inclusion. Secondary outcomes
      include validated Leeds Dyspepsia Questionnaire, Nepean dyspepsia index, etc.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The proportion of participants reporting complete absence of dyspeptic symptoms</measure>
    <time_frame>at 16 weeks after inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>validated Leeds Dyspepsia Questionnaire</measure>
    <time_frame>4, 8, 16, 20, 24 weeks after inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nepean dyspepsia index</measure>
    <time_frame>4, 8, 16, 20, 24 weeks after inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events in each group</measure>
    <time_frame>4 weeks after inclusion</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Functional Dyspepsia</condition>
  <condition>Postprandial Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>acupuncture group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use traditional acupuncture to treat functional dyspepsia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham acupuncture group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>use penetrating sham acupuncture to manage functional dyspepsia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>acupuncture</intervention_name>
    <description>In this group, acupuncture is given according to traditional acupuncture theories.</description>
    <arm_group_label>acupuncture group</arm_group_label>
    <other_name>use hwato acupuncture needles</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham acupuncture</intervention_name>
    <description>Sham acupuncture points will be used in this trial, with needle penetration.</description>
    <arm_group_label>sham acupuncture group</arm_group_label>
    <other_name>verum acupuncture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consistent with the diagnostic criteria of functional dyspepsia.

          -  Age of a subject is older than 18 and is younger than 65.（including 18 and 65）

          -  Include postprandial distress syndrome.

          -  Did not take any gastroenteric dynamic drugs in the last 15 days, and did not take
             part in any clinical trial.

          -  Informed consent is signed by a subject or his lineal relation.

        Exclusion Criteria:

          -  Patients with any contraindications of Itopride.

          -  Patients who are unconscious, psychotic.

          -  Patients with aggravating tumor and other serious consumptive disease, and who are
             subject to infection and bleeding.

          -  With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal,
             hematological systems and so on.

          -  Pregnant women or women in lactation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fan-rong Liang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chengdu University of TCM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fan-rong Liang</last_name>
    <phone>86-13438151411</phone>
    <email>acuresearch@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chengdu University of TCM</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610075</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fan-rong Liang, MD</last_name>
      <phone>86-13438151411</phone>
      <email>acuresearch@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Ma TT, Yu SY, Li Y, Liang FR, Tian XP, Zheng H, Yan J, Sun GJ, Chang XR, Zhao L, Wu X, Zeng F. Randomised clinical trial: an assessment of acupuncture on specific meridian or specific acupoint vs. sham acupuncture for treating functional dyspepsia. Aliment Pharmacol Ther. 2012 Mar;35(5):552-61. doi: 10.1111/j.1365-2036.2011.04979.x. Epub 2012 Jan 16.</citation>
    <PMID>22243034</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 8, 2013</lastchanged_date>
  <firstreceived_date>August 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Functional dyspepsia</keyword>
  <keyword>postprandial distress syndrome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
